Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: '749 Reexams ordered merged

Re: '749 Reexams ordered merged

posted on Sep 30, 2009 12:55AM

The good news about this reexam merge is that the first one began in March 2008, 18 months ago. With any luck, USPTO is well underway with it. Another thing I believe that may be to our advantage is the 749 includes all the individual patents rolled into one. It likely will make more sense to the examiner. I wonder if all the updates and revisions that were made in the individual patents will need to be changed during this reexam?

With regards to the Infineon rumor. This would be a chip manufacturer license. It almost appears the language we are reading describes in detail the lack of support Infineon would provide to any down stream manufacturers? Infineon at one time was owned by Siemens, another likely future licensee from Germany.

GLAL

Share
New Message
Please login to post a reply